During the past decade, Wake Research TN conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Wake Research TN" are "Genetic Obesity" (1 trials), "Obesity" (1 trials), "Obesity Associated With Defects in Leptin-melanocortin Pathway" (1 trials) and "Obesity Due to Melanocortin 4 Receptor Deficiency" (1 trials). Many other conditions were trialed in "Wake Research TN" in a lesser frequency.

Most popular intervention types in "Wake Research TN" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Setmelanotide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wake Research TN" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Wake Research TN". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in Wake Research TN, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wake Research TN, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".